Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, Surgery Partners, Inc. reported revenue of $3.31B, up 6.2% year over year. Operating margin was 11.8% and net margin -2.4%, on a free-cash-flow margin of 5.9% with capital expenditure at 2.4% of revenue. Every figure is computed directly from SGRY's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $3.31B | 11.8% | -2.4% |
| FY2024 | $3.11B | 11.2% | -5.4% |
| FY2023 | $2.74B | 12.0% | -0.4% |
| FY2022 | $2.54B | 13.6% | -2.2% |
| FY2021 | $2.23B | 13.6% | -3.2% |
How does SGRY compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: AACG · ABSI · ACCS · ACHC · ACM · ADUS
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.